Abstract We examined whether prostaglandin (PG) H 2 , as an endothelium-dependent contracting factor, or the disturbed production of endothelium-derived relaxing factor, impairs endothelium-dependent relaxation and whether longterm inhibition of nitric oxide (NO) synthesis aggravates atherosclerosis in hypercholesterolemic rabbits. Male New Zealand White rabbits were fed one of the following diets: (1) standard chow; (2) 2% cholesterol-supplemented chow; (3) standard chow with 80 /ig/mL Af"-nitro-L-arginine methylester (L-NAME), an NO synthetase inhibitor, in their drinking water; or (4) 2% cholesterol-supplemented chow with 80 or 160 fjig/mL L-NAME in their drinking water. The rabbits were fed these diets for 8 or 12 weeks. Then aortic rings were obtained, and changes in isometric tension were recorded. Intimal atherosclerotic areas of the thoracic aortas were subsequently measured by planimetry. The cholesterol-supplemented diet significantly impaired endothelium-dependent T he endothelium produces various substances such as endothelium-derived contracting factors (EDCFs) 1 -2 and endothelium-derived relaxing factor (EDRF) 2 4 and controls vascular smooth muscle tone. Several substances, such as thromboxane (TX) A 2 , 5 -6 superoxide anion, 7 endothelin, 8 and prostaglandin (PG) H 2 912 may be candidates for EDCFs and are considered responsible for various pathological disorders. We have reported that increased release of PGH 2 as an EDCF, not decreased EDRF activity, is responsible for impaired endothelium-dependent relaxation in response to acetylcholine (Ach) in thoracic aortas of old Wistar-Kyoto rats (WKYs), 910 spontaneously hypertensive rats (SHRs), 911 and diabetic rats.
T he endothelium produces various substances such as endothelium-derived contracting factors (EDCFs) 1 -2 and endothelium-derived relaxing factor (EDRF) 2 4 and controls vascular smooth muscle tone. Several substances, such as thromboxane (TX) A 2 , 5 -6 superoxide anion, 7 endothelin, 8 and prostaglandin (PG) H 2 912 may be candidates for EDCFs and are considered responsible for various pathological disorders. We have reported that increased release of PGH 2 as an EDCF, not decreased EDRF activity, is responsible for impaired endothelium-dependent relaxation in response to acetylcholine (Ach) in thoracic aortas of old Wistar-Kyoto rats (WKYs), 910 spontaneously hypertensive rats (SHRs), 911 and diabetic rats. 12 These observations suggest that PGH 2 may also play an important role in the impaired endothelium-dependent relaxation induced by atherosclerosis. The main component of EDRF has been identified as either nitric oxide (NO) 1315 or S-nitrosocysteine 16 and is derived from the metabolism of L-arginine. 15 EDRF not only is a potent vasodilator but also may have various effects on key events in atherosclerosis, such as platelet into three sets: those drinking untreated water (cholesterol diet/normal water group, n=18) and those drinking water containing either 80 or 160 /xg/mL L-NAME (cholesterol diet/L-NAME 80 group, n = l l ; cholesterol diet/L-NAME 160 group, n=12). L-NAME was administered throughout the course of the study.
After 8 and 12 weeks of dietary treatment, the central ear arteries of conscious restrained rabbits were cannulated by percutaneous puncture with a 24G cannula for measurement of intra-arterial blood pressure and blood sampling. Blood pressure was measured through the arterial cannula after the animal was allowed to rest quietly for at least 15 minutes. Then the rabbits were anesthetized with pentobarbital sodium (30 mg/kg) given via the marginal ear vein. Thoracic aortas were harvested for studies of vascular reactivity and morphometry. These protocols were approved by the animal ethics committee of Nagoya University.
Vascular Reactivity Studies
The thoracic aorta tissue was placed in cold Krebs-Henseleit solution of the following composition (millimoles per liter): NaCl 118, KC1 4.7, CaCl 2 2.55, MgSO 4 1.18, KH 2 PO 4 1.18, NaHCO 3 24.88, glucose 11.1, and Ca,Na 2 EDTA 0.026. The fat and connective tissue were removed, and thoracic aortas were cut with scissors into rings 5 mm long. Two stainless steel wires were inserted into the vascular lumen and one wire was connected to a force transducer (model TB-612T, Nihoncohden). The rings were suspended in an organ chamber containing 30 mL Krebs-Henseleit solution that was bubbled with a 95% O 2 /5% CO 2 mixture and maintained at 37°C. The rings were incubated for 90 minutes for equilibration at a resting tension of 3 g with buffer exchanges every 15 minutes during this period. The rings were manipulated carefully to avoid producing unnecessary tension or damage to the endothelium.
Aortic rings were subsequently contracted with norepinephrine (NE, 10"' mol/L), and after contraction reached a plateau, they were relaxed with a cumulative dose of Ach (10~9 mol/L to 10~4 mol/L). A TXA 2 /PGH 2 receptor antagonist, ONO-3708 (10~6 mol/L), was added to the bath 15 minutes before induction of contraction with NE. The response of aortic rings to Ach was examined in the cholesterol diet/ normal water group. The degree of relaxation was expressed as a percentage of the contraction induced by 10" 7 mol/L NE.
Morphometric and Histological Analyses
To investigate the effect of long-term administration of L-NAME on atherosclerosis development, morphometric and histological analyses of fatty plaque areas were performed. Thoracic aortas (from the left subclavian artery to the diaphragm) including the rings used for vascular reactivity studies were cut open longitudinally, and the intimal surface was examined for the presence of fatty plaques. The specimens were rinsed in 50% ethanol for 1 minute and immersed in Sudan red at 37°C for 120 minutes. Next, the tissues were transferred to 50% ethanol for 5 minutes, washed in running distilled water for 10 minutes, and stored in 10% buffered formalin. The total and lesioned areas were measured by planimetry of photographic images, and the degree of atherosclerosis was expressed as a percentage of the luminal surface area covered by lesions. After morphometric analysis, aortic segments were stained with hematoxylin-eosin and examined by light microscopy by a pathologist for the presence of atherosclerosis.
Drugs
The pharmacological agents used were L-NE bitartrate, Ach chloride, L-NAME (all from Sigma Chemical Co), and (9,11)-(ll,12)-dideoxa-9a,lla-dimethylmethano-ll,12-methano-13, 14-dihydro-13-aza-14-oxo-15-cyclopentyl-16,17,18,19,20-pentanor-15-epi-TXA 2 (ONO-3708; Ono Pharmaceutical Co). Drugs were dissolved in distilled water and concentrations expressed as the final concentration in the bath solution.
Statistical Analysis
Results were expressed as mean±SEM. For statistical analysis, Student's / tests for paired or unpaired observations were used. Values of P<.Q5 were considered significant.
Results

Typical Responses of Aortic Rings to Ach
Ach at 10~6 mol/L maximally relaxed the aortic rings precontracted with 10~7 mol/L NE. At higher concentrations, Ach induced contractions (Fig 1A) . On the other hand, Ach contracted but barely relaxed the rings without an endothelium (Fig IB) . Similarly, after pretreatment with 10~4 mol/L L -N A M E , Ach only contracted the rings (Fig 1C) .
Effect of Hypercholesterolemia
Biochemical and Physiological Measurements
At the start of the experiment, body weight was similar in the standard diet/normal water and cholesterol diet/normal water groups. Weight gain in the cholesterol diet/normal water group at 8 and 12 weeks was significantly lower than that in the standard diet/ normal water group. Rabbits in the cholesterol diet/ normal water group had higher total cholesterol and high-density lipoprotein cholesterol levels at 8 and 12 weeks compared with their counterparts in the standard diet/normal water group (Table 1) . (8) 27±4 (8) 14±3 (8) 59±9 (8) water group 2755 ±84 (6) 605±137 (6) (4) 26+4 (4) 16±4 (4) 30 ±6 (4) Cholesterol diet/L-NAME 80 group 
Weeks
2586±59 (5) 1248 ±147 (5) 20±3 (5) 12±2 (5) 54+30 (5) 2675±68 (12) 868±82 (12) (12) 38±14 (12) 2540±31 (4) 1043+52 (4) 25±6 (4) 18±4 (4) 33±15 (4) 2648 ±63 (5) 726±164 (5) 1649±396(5)* 22 ±2 (5) 72±30 (5) 2514±40 (6) 644±90 (6) 1903±110(6)*t 29±4 (6) 62 ±24 (6) -« -standard diet/normal water group -o-cholesterol diet/normal water group BW indicates body weight; total chol, total cholesterol; HDLchol, high-density lipoprotein cholesterol; TG, triglycerides; L-NAME, W-nitro-L-arginine methylester; and (n), number of animals examined.
*P<.05 vs standard diet/normal water group. tP<.05 vs cholesterol diet/normal water group.
Vascular Reactivity Studies
Maximal tension induced by 10" 7 mol/L NE in the cholesterol diet/normal water group was similar to that in the standard diet/normal water group: 0.91±0.08 versus 0.90±0.07 g at 8 weeks and 0.89±0.10 versus 0.87±0.15 g at 12 weeks. Aortic rings in the cholesterol diet/normal water group showed significantly less maximal relaxation in response to Ach than those in the standard diet/normal water group: 61.0±4.5% versus 81.5±2.7% at 8 weeks (P<.01) and 45.4±12.5% versus 87.2±4.0% at 12 weeks (P<.05) (Fig 2) . Pretreatment with the TXA 2 /PGH 2 receptor antagonist ONO-3708 did not reverse this impaired endothelium-dependent relaxation (Fig 3) . 
Effect of Orally Administered L-NAME Biochemical and Physiological Measurements
Body weight gain during the experiment as well as initial body weight in the cholesterol diet/L-NAME group was similar to that in the cholesterol diet/normal water group. The cholesterol diet/L-NAME 80 group had a total cholesterol level similar to that in the cholesterol diet/normal water group, although the total cholesterol level in the cholesterol diet/L-NAME 160 group was significantly higher than that in the cholesterol diet/normal water group (Table 1) . L -N A M E in drinking water did not affect systemic blood pressure (Table 2) . Rabbits in each group daily consumed a similar amount of drinking water.
Vascular Reactivity Studies
Maximal tensions induced by 10" 7 mol/L NE in aortic rings from the standard diet/normal water and the standard diet/L-NAME 80 groups were 0.90±0.07 and 1.02±0.05 g, respectively, at 8 weeks and 0.87±0.15 and SBP indicates systolic blood pressure; DBP, diastolic blood pressure; L-NAME, W"-nitro-L-arginine methylester; and (n), number of animals examined.
0.98±0.05 g, respectively, at 12 weeks. Corresponding values in the cholesterol diet/normal water, cholesterol diet/L-NAME 80, and cholesterol diet/L-NAME 160 groups were 0.91±0.08, 0.93±0.08, and 0.96±0.07 g, respectively, at 8 weeks and 0.89 ±0.10, 0.85 ±0.15, and 0.90±0.09 g respectively, at 12 weeks. Oral administration of L-NAME did not affect NE-induced maximal tension of aortic rings from both normocholesterolemic and hypercholesterolemic rabbits.
Aortic rings from the standard diet/L-NAME 80 group showed more impaired maximal relaxation to Ach compared with those from the standard diet/normal water group: 58.7±2.3% versus 81.5±2.7% at 8 weeks (i><.01) and 50.9±4.2% versus 87.2±4.0% at 12 weeks (P<.01) (Fig 4) . The cholesterol diet/L-NAME 80 group had markedly less maximal relaxation of aortic rings in response to Ach than did the cholesterol diet/normal water group: 30.3±7.3% versus 61.0±4.5% at 8 weeks (P<.05) and 7.1 ±9.1% versus 45.4+12.5% at 12 weeks (P<.05) (Fig 5) . This was also true for the cholesterol diet/L-NAME 160 group: 27.4±8.6% versus 61.0±4.5% at 8 weeks (P<.05) and 18.1±1.6% versus 45.4±12.5% at 12 weeks (F<.05) (Fig 5) . L -N A M E in drinking water impaired maximal aortic ring relaxation to Ach in hypercholesterolemic as well as normocholesterolemic rabbits.
Morphometric and Histological Analyses
Thoracic aortas from normocholesterolemic rabbits had no evidence of atheromatous lesions. The percentages of fatty plaque areas in thoracic aortas from rabbits in the cholesterol diet/L-NAME 80 and cholesterol diet/L-NAME 160 groups were 15.2±4.4% and 25.5±7.2%, respectively, at 8 weeks and 74.7±9.7% and 57.3±4.9%, respectively, at 12 weeks. Corresponding values in the cholesterol diet/normal water group were 4.7 ±2.0% at 8 weeks and 23.8±6.9% at 12 weeks (Fig 6) . Oral administration of L -N A M E for 8 and 12 weeks significantly promoted atherosclerotic lesions in hypercholesterolemic rabbits. Histological study of the aortas demonstrated typical atherosclerotic changes both in hypercholesterolemic rabbits given L -N A M E and in those not given L-NAME. However, atherosclerotic lesions were more advanced in rabbits given L-NAME.
Discussion
Effect of PGH 2 on Vascular Responses in Atherosclerotic Rabbits
The vascular endothelium produces EDCFs 1 -2 as well as EDRF 2 4 and controls vascular smooth muscle tone, and imbalance between these factors seems to augment vascular tone in various pathological states. In the rat thoracic aorta, vascular relaxation occurs through EDRF production in response to low concentrations of
8
• cholesterol diet/normal water group D cholesterol diet/L-NAME 80 group % cholesterol diet/L-NAME 160 group FIG 6 . Planimetry of lesion surface area. Descending thoracic aortas were photographed for planimetry after Sudan red staining to assess intimal lipid accumulation in the cholesterol diet/ normal water, cholesterol diet/L-NAME 80, and cholesterol diet/ L-NAME 160 groups at 8 (left) and 12 (right) weeks of dietary intervention. *P<.05, **P<.01 compared with the cholesterol diet/normal water group. Numbers under each horizontal axis refer to the number of animals in each group. L-NAME indicates W"-nitro-L-arginine methylester.
Ach, but high concentrations of Ach cause vascular contraction. We have revealed that this contractile response is due to endothelium-derived PGH 2 in old WKYs, 910 SHRs, 911 and diabetic rats. 12 In this study, we examined whether similar changes occurred in the hypercholesterolemic rabbit thoracic aorta.
Thoracic aortas of normocholesterolemic rabbits showed relaxation and contractile responses to Ach similar to those of rats. Vascular relaxation was inhibited by pretreatment with L -N A M E , which indicated that this relaxation response was attributable to EDRF. However, contraction also was noted in vascular specimens from which the endothelium had been removed, suggesting that this contractile response was not mediated through the action of the endothelium but rather by a direct action of Ach on vascular smooth muscle.
In aortic rings from hypercholesterolemic rabbits, vascular relaxation in response to Ach was weaker than that of rings from normocholesterolemic rabbits. No significant difference in the direct contractile effects of Ach was observed in endothelium-denuded aortas in normocholesterolemic and hypercholesterolemic rabbits. Therefore, reduction in the relaxation response to Ach seems to be due to the impaired endotheliumdependent relaxation. This impaired endothelium-dependent relaxation has been reported in atherosclerotic rabbits. 21 
"
23 Several factors, such as an abnormality in synthesizing and/or releasing EDRF, 2425 enhanced release of inactivated forms of NO and its related compounds, 25 deactivation of NO by free radicals, 2628 and impaired cholinoceptor activity, 29 have been proposed as possible causes, but the exact mechanism of this impaired relaxation remains unknown. We hypothesize that PGH 2 as an EDCF also contributes to attenuation of the endothelium-dependent relaxation in atherosclerotic rabbits, as occurs in hypertensive and diabetic rats. However, ONO-3708, a PGH 2 /TXA 2 receptor antagonist, had no effect on the attenuated relaxation response, which indicated that participation of PGH 2 in the process was unlikely. There were no differences in vascular relaxation responses to sodium nitroprusside and the response to Ach in specimens pretreated with L-NAME between normocholesterolemic and hypercholesterolemic rabbits (data not shown). Therefore, our findings indicate that reduced production of endothelium-derived NO rather than stimulated EDCF synthesis seems to attenuate the endothelium-dependent vascular response and may lead to enhanced formation of atherosclerotic lesions in hypercholesterolemic rabbits. Changes in vascular responses may vary with various species and pathological states.
Effect of Long-term Administration of L-NAME on Atherosclerosis Progression
Numerous factors have been implicated in the initiation and development of atherosclerosis, including blood pressure, plasma cholesterol levels, lipoprotein oxidation, vascular smooth muscle tone, and platelet aggregation. Therapies that attenuate atherogenesis usually do so by affecting one or more of these factors. It has been reported that calcium channel blockers, 30 TXA 2 inhibitors, 31 angiotensin-converting enzyme inhibitors, 32 and probucol, an antioxidant,
33
-34 inhibit atherosclerosis progression.
Recently, the relationship between NO and atherosclerosis has attracted attention. NO is known to be present not only in the vascular endothelium but also in the central nervous system, 3536 peripheral nerves, 37 kidney, 38 pancreas, 39 and macrophages. 4041 Endothelium-derived NO, which acts as an EDRF, and macrophage-derived NO coexist in atherosclerotic lesions, but their functional relationship has not been clarified.
To evaluate the roles of NO in the pathogenesis of atherosclerosis, we examined the effects of long-term administration of L -N A M E , which inhibits NO synthetase, on atherosclerosis progression. Long-term oral administration of L -N A M E significantly diminished Ach-induced relaxation of aortic rings from normocholesterolemic rabbits. The relaxation response was almost completely abolished either by removal of the endothelium or by ex vivo pretreatment with L -N A M E (data not shown), which indicates that reduced synthesis of endothelium-derived NO may be responsible for attenuation of the relaxation response. No atherosclerotic lesions were found in specimens from normocholesterolemic rabbits. In hypercholesterolemic rabbits, endothelium-dependent relaxation was more impaired and the atherosclerotic lesion area was markedly enlarged by administration of L-NAME at concentrations of both 80 /xg/mL and 160 fig/mL in drinking water.
We measured two variables that may be responsible for atherosclerosis progression, one of which is the serum cholesterol level. It is especially important to note that L -N A M E at 80 /ig/mL appears to have a small but not statistically significant effect on cholesterol level and that at the higher concentration (160 /xg/mL) the effect is significant. However, it should be noted that L -N A M E at both concentrations promoted atherosclerosis. Therefore, the effect of L -N A M E on atherosclerosis is reasonably considered to be derived from its inhibition of NO synthesis but not from its hypercholesterolemic effect, if L -N A M E has such an effect at all. The other variable that we measured was blood pressure. Administration of an NO synthetase inhibitor has been reported to elevate blood pressure in rats 42 - 44 and rabbits, 45 -46 but in our study, long-term oral administration of L-NAME did not raise blood pressure despite a by guest on November 9, 2017 http://atvb.ahajournals.org/ Downloaded from reduced endothelium-derived NO production, as indicated by impaired relaxation of aortic rings in response to Ach. Differences in species or routes of administration could explain the discrepancy between our results and those of others. In previous studies, rabbits were administered L -N A M E as a bolus intravenous injection, 4546 whereas ours used an oral long-term administration of L-NAME dissolved in drinking water. Our method may maintain lower but more stable serum L-NAME levels. Even though a precise underlying mechanism has not been clarified, our results indicate that L -N A M E can exacerbate atherosclerosis without raising blood pressure.
The mechanism by which L -N A M E exerts its atherogenic effects in hypercholesterolemic rabbits is still unclear. Endothelium-derived NO production was obviously suppressed by oral administration of L -N A M E in our study, because the aortic rings showed an attenuated relaxation response to Ach. NO not only is a potent vasodilator but also has an inhibitory effect on platelet adhesion and aggregation. 1719 NO has also been reported to inhibit monocyte adherence to cultured endothelial cells 47 and to control endothelial permeability.
48
- 49 Our results suggest that L -N A M E inhibits the antiatherogenic effects of NO and thus promotes atherosclerosis. A recent finding supports our results by showing that long-term oral administration of L-arginine, the metabolic precursor for NO, reverses the attenuated endothelium-dependent relaxation of aortic rings in response to Ach and prevents atherosclerosis development in hypercholesterolemic rabbits. 50 Thus, reduced production of endothelium-derived NO is atherogenic and increased production antiatherogenic, indicating that NO may play a crucial role in preventing atherosclerosis. However, NO derived from cells other than endothelial cells may contribute to the antiatherogenic effect. 51 It is also possible that L -N A M E may directly (not through inhibition of NO synthesis) act on monocyte adherence or infiltration, platelet reactivity, or other key process in atherogenesis, but there has been no evidence to support these hypotheses. Our findings indicate that long-term oral administration of L -N A M E enhances atherosclerosis progression in the aorta of hypercholesterolemic rabbits by inhibiting NO production.
Conclusions
The endothelium-derived vascular relaxation response is diminished in the atherosclerotic rabbit thoracic aorta. Unlike its role in hypertensive and diabetic rats, PGH 2 as an EDCF is not responsible for this impaired endothelium-dependent relaxation. Rather, our findings suggest that this phenomenon is attributable to the reduction in NO synthesis or release. In addition, reduced production of NO in the aortic wall, which has also been observed in animals after long-term oral administration of L-NAME, further enhanced atherosclerosis progression, thus creating a vicious circle of pathophysiological events.
